CIK 0000943819 · Large accelerated filer
RESMED INC
Sign in to watch- Tickers
- RMD RSMDF
- Exchange
- NYSE, OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980152841
- Phone
- 8587462400
- Business address
- 9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA, 92123
Securities
- RMD ResMed Inc. Common Stock NYSE
- RSMDF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,744,605
- in 5 filings, $3.7M under 10b5-1 plans
Net −$3,744,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-15 | Farrell Michael J. Chief Executive Officer | Sale 10b5-1 | −5,675 | $217.39 | $1.2M | 436,930 |
| 2023-06-15 | Farrell Michael J. Chief Executive Officer | Option exercise · ResMed Common Stock Options 10b5-1 | −5,675 | 31,840 | ||
| 2023-06-05 | PENDARVIS DAVID Chief Administrative Officer | Sale 10b5-1 | −1,500 | $219.79 | $330K | 89,729 |
| 2023-06-02 | Ghoshal Kaushik President, SaaS Business | Sale 10b5-1 | −500 | $220.00 | $110K | 12,287 |
| 2023-05-15 | Farrell Michael J. Chief Executive Officer | Option exercise 10b5-1 | +5,675 | $57.76 | $328K | 442,605 |
| 2023-05-15 | Farrell Michael J. Chief Executive Officer | Sale 10b5-1 | −5,675 | $232.10 | $1.3M | 436,930 |
| 2023-05-15 | Farrell Michael J. Chief Executive Officer | Option exercise · ResMed Common Stock Options 10b5-1 | −5,675 | 37,515 | ||
| 2023-05-15 | Douglas Robert Andrew President and COO | Sale 10b5-1 | −1,500 | $232.85 | $349K | 255,026 |
| 2023-05-10 | Sandercock Brett Chief Financial Officer | Sale | −12,574 | $233.13 | $2.9M | 90,942 |
| 2023-05-09 | Sandercock Brett Chief Financial Officer | Sale | −3,426 | $232.05 | $795K | 103,516 |
| 2023-05-03 | FARRELL PETER C Director | Sale | −12,600 | $237.17 | $3.0M | 166,896 |
| 2023-05-03 | PENDARVIS DAVID Chief Administrative Officer | Sale 10b5-1 | −1,500 | $237.64 | $356K | 91,172 |
| 2023-05-01 | Ghoshal Kaushik President, SaaS Business | Sale 10b5-1 | −500 | $239.30 | $120K | 12,704 |
| 2023-04-24 | Ghoshal Kaushik President, SaaS Business | Sale | −2,000 | $230.00 | $460K | 13,204 |
| 2023-04-17 | Douglas Robert Andrew President and COO | Sale 10b5-1 | −1,500 | $224.65 | $337K | 256,526 |
| 2023-04-17 | Farrell Michael J. Chief Executive Officer | Option exercise 10b5-1 | +5,675 | $57.76 | $328K | 442,575 |
| 2023-04-17 | Farrell Michael J. Chief Executive Officer | Sale 10b5-1 | −5,675 | $224.23 | $1.3M | 436,900 |
| 2023-04-17 | Farrell Michael J. Chief Executive Officer | Option exercise · ResMed Common Stock Options 10b5-1 | −5,675 | 43,190 | ||
| 2023-04-03 | PENDARVIS DAVID Chief Administrative Officer | Sale | −1,500 | $218.23 | $327K | 92,672 |
| 2023-04-03 | Ghoshal Kaushik President, SaaS Business | Sale | −500 | $220.00 | $110K | 15,204 |
Page 20 of 28 · 548 trades